Susfectin™ Transfection Reagent

As an industry leader in recombinant viral vectors (lentivirus, adenovirus, and AAV), abm has 15+ years of experience in how to enhance virus vector transduction efficiency. Over the years, we have developed multiple formulations of viral enhancing agents useful for this purpose. A remarkable breakthrough by our top scientists in 2020 is the development of the most efficient viral enhancing agent, ViralEntry™, that is not only effective in enhancing both lentiviral and AAV vector transduction efficiency significantly, but also increases transduction efficiency in diverse cell types including primary T lymphocytes by over 10X. This is superior to any similar product on the market.